Overlapping structure of hepatitis B virus (HBV) genome and immune selection pressure are critical forces modulating HBV evolution

Increased Seroprevalence of HBV DNA With Mutations in the S Gene Among Individuals Greater Than 18 Years Old After Complete Vaccination

(2012) Ming–Wei Lai et al.   GASTROENTEROLOGY

RNA interference and its potential applications to chronic HBV treatment: results of a Phase I safety and tolerability study

(2011) Robert G Gish et al.   ANTIVIRAL THERAPY

Immune-Induced Evolutionary Selection Focused on a Single Reading Frame in Overlapping Hepatitis B Virus Proteins

(2011) Y. Maman et al.   JOURNAL OF VIROLOGY

Breakthrough HBV infection in vaccinated children in Taiwan: surveillance for HBV mutants

(2010) Mei-Hwei Chang   ANTIVIRAL THERAPY

Molecular genesis of drug-resistant and vaccine-escape HBV mutants

(2010) Stephen A Locarnini et al.   ANTIVIRAL THERAPY

RNA Interference inhibits Hepatitis B Virus of different genotypes in Vitro and in Vivo

(2010) Ya-Li Zhang et al.   BMC MICROBIOLOGY

Potential of carbohydrate-binding agents as therapeutics against enveloped viruses

(2010) K. O. François et al.   MEDICINAL RESEARCH REVIEWS

Pathogenesis of hepatitis B virus infection

(2010) F.V. Chisari et al.   PATHOLOGIE BIOLOGIE

Chronic hepatitis B: Update 2009

(2009) Anna S. F. Lok et al.   HEPATOLOGY

The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B

(2008) Brian J. McMahon   Hepatology International